The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $197.67, a high ...

The U.S. Food and Drug Administration approved Zevra Therapeutics' drug for a rare and fatal genetic disorder, the first ...

Shares of Nike (NKE) are rallying after the company announced that CEO John Donahoe will be stepping down next month after a ...

Adrienne Yih, Barclays U.S. retail senior analyst, joins 'Squawk Box' to discuss news of Nike CEO John Donahoe stepping down, ...

In a report released today, Jay Sole from UBS maintained a Hold rating on Nike (NKE – Research Report), with a price target of $78.00.

The major averages are searching for direction this morning after the Dow (^DJI) and S&P 500 (^GSPC) both closed at record ...

The iOS 18.1 public beta is here, bringing Apple Intelligence (almost) to the masses, US citizens can now apply for their ...

In a report released today, Adrienne Yih from Barclays maintained a Buy rating on Deckers Outdoor (DECK – Research Report), with a price ...

CEO John Donahoe will be stepping down Oct. 13, and will remain an advisor to the company through Jan. 31. He will be ...

NIKE ousted beleaguered chief executive John Donahoe, bringing long-time executive Elliott Hill out of retirement to return ...